ORPHA:567983
Parenteral nutrition-associated cholestasis
Also known as: PNAC
Publications
438
82.1th percentile
Trials
10
Interventional, condition-specific
Researchers
967
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare hepatic disease characterized by intrahepatic cholestasis and deterioration of liver function in patients receiving parenteral nutrition for extended periods of time (signs may appear as early as within the first two weeks of initiation of parenteral nutrition). The condition commonly occurs in neonates and usually resolves with transition to enteral feeding, although severe cases may progress to liver fibrosis, cirrhosis, and portal hypertension.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0035777
- UMLS:C3274301
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
438 matched papers (254 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
10 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
438
438 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
438 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
254 in the last 10 years · medium confidence · 82.1th percentile (publications denominator)
Phrase hits: 438 · MeSH hits: 0
Who's working on it?
967
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Sokol RJ13 papers · 2026
Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, CO, 80045, USA. Ronald.Sokol@childrenscolorado.org.
Papers in Europe PMC - 02Mao J12 papers · 2025
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Papers in Europe PMC - 03Lin XZ11 papers · 2025
Department of Neonatology, Xiamen Maternal and Child Care Hospital, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China.
Papers in Europe PMC - 04Wu F11 papers · 2024
Department of Neonatology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Papers in Europe PMC - 05Devereaux MW10 papers · 2026
Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Papers in Europe PMC - 06Shen W10 papers · 2024
Department of Neonatology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China.
Papers in Europe PMC - 07Zhang J10 papers · 2026
Department of Pediatrics, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China.
Papers in Europe PMC - 08Zhu Y9 papers · 2026
Department of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China; Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. Electronic address: njglyyzhuy@cpu.edu.cn.
Papers in Europe PMC - 09Ghosh S8 papers · 2026
Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
Papers in Europe PMC - 10Tong XM8 papers · 2024
Department of Pediatrics, Peking University Third Hospital, Beijing, China. tongxm2022@126.com.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
10
interventional trials for this specific condition
10 interventional trials matched this specific condition name; 1 currently recruiting in our sample. 91 trials are registered for cholestasis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
10 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 91.7th percentile).
medium confidence · 91.7th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
10 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06049680·RECRUITING·Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Conditions: Malnutrition, Child · Malnutrition · Essential Fatty Acid Deficiency (EFAD) · Parenteral Nutrition Associated Cholestasis·Matched via name phrase
Broader category: cholestasis
91
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07290257·RECRUITING·Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)
Conditions: Alagille Syndrome · Progressive Familial Intrahepatic Cholestasis·Matched via name phrase
- NCT07569003·RECRUITING·Prealbumin and IGF-1 Levels in Pediatric Chronic Cholestasis With Severe Malnutrition After Nutrition Therapy
Conditions: Chronic Cholestasis · Severe Malnutrition · Pediatric Cholestasis·Matched via name phrase
- NCT07389031·NOT YET RECRUITING·Maralixibat for Intrahepatic Cholestasis of Pregnancy
Conditions: Intrahepatic Cholestasis of Pregnancy·Matched via name phrase
- NCT07250854·RECRUITING·The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
Conditions: Biliary Atresia · Kasai · Cholestasis in Newborn · Cholestasis in Newborn Infant·Matched via name phrase
- NCT07378761·NOT YET RECRUITING·Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic Hepatitis
Conditions: Immune-Mediated Cholestasis·Matched via name phrase
- NCT06628726·NOT YET RECRUITING·Liver Biopsy in Diagnosis Neonatal Jaundice
Conditions: Neonatal Cholestasis · Neonatal Jaundice·Matched via name phrase
- NCT07317193·RECRUITING·DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE
Conditions: Cholestatic Liver Disease · Progressive Familial Intrahepatic Cholestasis·Matched via name phrase
- NCT07560722·NOT YET RECRUITING·The Effect of a Single Intravenous Injection of Esketamine During Cesarean Section on Postoperative Pruritus in Patients With Intrahepatic Cholestasis of Pregnancy
Conditions: Intrahepatic Cholestasis of Pregnancy·Matched via name phrase
Observational and natural-history studies
2 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Parenteral nutrition-associated cholestasis"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Parenteral nutrition-associated cholestasis"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 10 interventional · 2 observational · 1 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"cholestasis"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: PNAC
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T18:29:01.570Z
